Who is sponsoring NCT05983861?

NCT05983861 is sponsored by José Raimundo Araujo de Azevedo.

What drugs are being tested in NCT05983861?

Interventions in NCT05983861: Identification o Multi Drug Resistant Bacteria.

What condition does NCT05983861 study?

NCT05983861 studies Multi Drug Resistant Bacteria.

Is NCT05983861 still recruiting?

NCT05983861 is currently status unknown. Last updated 9 August 2023.

Last reviewed 2023-08-09 · How we verify

NCT05983861

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk Factors for Multidrug Resistant Bacteria at ICU Admission

Status unknown Last updated 9 August 2023

What this trial tests

trial testing Identification o Multi Drug Resistant Bacteria in Multi Drug Resistant Bacteria in 400 participants. Status unknown.

Timeline

1 September 2023

Primary endpoint
31 August 2024

31 January 2025

Quick facts

Lead sponsor	José Raimundo Araujo de Azevedo
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	400
Start date	1 September 2023
Primary completion	31 August 2024
Estimated completion	31 January 2025

Drugs / interventions tested

Identification o Multi Drug Resistant Bacteria

Conditions studied

Multi Drug Resistant Bacteria — all drugs for Multi Drug Resistant Bacteria →

Sponsor

José Raimundo Araujo de Azevedo — full company profile →

Who can join

18 and older, any sex, with Multi Drug Resistant Bacteria. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this single-center prospective observational study is to evaluate possible independent risk factors for multidrug-resistant (MDR) bacteria upon ICU admission by analyzing comorbidities, epidemiological data, and laboratory/microbiological information of the subjects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05983861 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by José Raimundo Araujo de Azevedo
Last refreshed: 9 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05983861.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing